within Pharmacolibrary.Drugs.N_NervousSystem.N06A_Antidepressants.N06AX08_Bifemelane;

model Bifemelane
  extends Pharmacolibrary.Drugs.ATC.N.N06AX08;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>N06AX08</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Bifemelane is a psychoactive drug developed in Japan, primarily used as an antidepressant and cerebral activator. It is mainly prescribed for the treatment of depression, dementia, and cognitive dysfunction due to cerebrovascular disorder. It acts as a monoamine oxidase inhibitor (MAOI) and also possesses neuroprotective effects. It is not widely approved outside Japan.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for healthy adult Japanese subjects after single oral administration.</p><h4>References</h4><ol><li><p>Gillis, JC, et al., &amp; McTavish, D (1994). Idebenone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in age-related cognitive disorders. <i>Drugs &amp; aging</i> 5(2) 133â€“152. DOI:<a href=\"https://doi.org/10.2165/00002512-199405020-00007\">10.2165/00002512-199405020-00007</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7981485/\">https://pubmed.ncbi.nlm.nih.gov/7981485</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Bifemelane;
